Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 445S-469S

  Hirsh, Jack ^a   Dalen, James E ^a   Anderson, David R ^a   Poller, Leon ^a   Bussey, Henry ^a   Ansell, Jack ^a   Deykin, Daniel ^a   Brandt, John T ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMINOGLUTETHIMIDE DERIVATIVE; AMIODARONE; ANABOLIC AGENT; ANTICOAGULANT AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CIMETIDINE; COLESTYRAMINE; COTRIMOXAZOLE; DICLOXACILLIN; ERYTHROMYCIN; GRISEOFULVIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; NAFCILLIN; OMEPRAZOLE; PHENYLBUTAZONE; PHENYTOIN; PHYTOMENADIONE; RIFAMPICIN; SULFINPYRAZONE; SULFONAMIDE; WARFARIN;

ACUTE HEART INFARCTION; ANTICOAGULATION; AUTOMATION; BLEEDING; BONE METABOLISM; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFECT; DRUG MECHANISM; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART VALVE PROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MONITORING; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN TIME; SELF CARE; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM;

EID: 0031729679     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Whitlon DS, Sadowski JA, Suttie JW. Mechanisms of coumarin action: significance of vitamin K epoxide reductase inhibition. Biochemistry 1978; 17:1371-1377
2. Fasco MJ, Hildebrandt EF, Suttie JW. Evidence that warfarin anticoagulant action involves two distinct reductase activities. J Biol Chem 1982; 257:11210-11212
3. Choonara IA, Malia RG, Haynes BP, et al. The relationship between inhibition of vitamin K 1,2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br J Clin Phannacol 1988; 25:1-7
4. Trivedi LS, Rhee M, Galivan JH, et al. Normal and warfarinresistant rat hepatocyte metabolism of vitamin K 2,3 epoxide: evidence for multiple pathways of hydroxyvitamin K formation. Arch Biochem Biophys 1988; 264:67-73
5. Stenflo J, Fernlund P, Egan W, et al. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc NatI Acad Sci USA 1974; 71:2730-2733
6. Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of γ-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974; 249:6347-6350
7. Nelsestuen GL. Role of gamma-carboxyglutamic acid: an unusual transition required for calcium-dependent binding of prothrombin to phospholipid. J Biol Chem 1976; 251: 5648-5656
8. Prendergast FG, Mann KG. Differentiation of metal ioninduced transitions of prothrombin fragment 1. J Biol Chem 1977; 252:840-850
9. Borowski M, Furie BC, Bauminger S, et al. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. J Biol Chem 1986; 261: 14969-14975
10. Friedman PA, Rosenberg RD, Hauschka PV, et al. A spectrum of partially carboxylated prothrombins in the plasmas of coumarin treated patients. Biochim Biophys Acta 1977; 494:271-276